Form 4 holding
CEO, Director, 10%+ Owner
Blue Water Biotech, Inc.
- Security class
- Common Stock
- Shares / value
- 2,800,351
- Estimated value
- $11,490,960
- Report date
- 09 May 2023
- Price
- $4.10
- Ownership
- Direct
Joseph Hernandez
Insider Reports History
- Reporting-owner location
- New York, NY
- Latest reporting-owner signature
-
/s/ Joseph Hernandez
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Joseph Hernandez
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Blue Water Acquisition Corp. III
- Security class
- Class A ordinary shares
- Shares / value
- 430,000
- Estimated value
- $4,317,200
- Report date
- 25 Nov 2025
- Price
- $10.04
- Ownership
- Indirect
Form 4 holding
Director, Former 10% owner
CLARUS THERAPEUTICS INC
- Security class
- Warrant
- Shares / value
- 3,445,000
- Estimated value
- Report date
- 09 Sep 2021
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, Former 10% owner
CLARUS THERAPEUTICS INC
- Security class
- Common Stock
- Shares / value
- 1,302,500
- Estimated value
- Report date
- 09 Sep 2021
- Price
- Ownership
- Indirect
Form 4 holding
Director
Clarus Therapeutics Holdings, Inc.
- Security class
- Common Stock
- Shares / value
- 1,243,266
- Estimated value
- Report date
- 07 Jun 2022
- Price
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Blue Water Acquisition Corp. IV
- Security class
- Class A ordinary shares
- Shares / value
- 275,000
- Estimated value
- Report date
- 23 Mar 2026
- Price
- Ownership
- Indirect
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Blue Water Acquisition Corp. IV
- Security class
- Warrants to purchase Class A ordinary shares
- Shares / value
- 137,500
- Estimated value
- Report date
- 23 Mar 2026
- Price
- Ownership
- Indirect
- Underlying class
- Class A ordinary shares
- Underlying amount
Form 4 holding
Director
Clarus Therapeutics Holdings, Inc.
- Security class
- Common Stock
- Shares / value
- 65,000
- Estimated value
- Report date
- 07 Jun 2022
- Price
- Ownership
- Indirect
Form 4 holding
Director
Clarus Therapeutics Holdings, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 4,805
- Estimated value
- Report date
- 07 Jun 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Blue Water Acquisition Corp. III
- Security class
- Class B ordinary shares
- Shares / value
- 0
- Estimated value
- Report date
- 25 Nov 2025
- Price
- Ownership
- Indirect
- Underlying class
- Class A Ordinary Shares
- Underlying amount
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Blue Water Acquisition Corp. III
- Security class
- Warrants to purchase Class A ordinary shares
- Shares / value
- 0
- Estimated value
- Report date
- 25 Nov 2025
- Price
- Ownership
- Indirect
- Underlying class
- Class A ordinary shares
- Underlying amount
Form 4 holding
Director, Former 10% owner
CLARUS THERAPEUTICS INC
- Security class
- Class B Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 09 Sep 2021
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Joseph Hernandez
4
BWIV
Blue Water Acquisition Corp. IV
- Report period
- 23 Mar 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 24 Mar 2026, 16:30
- Role
- Chief Executive Officer, Director, 10%+ Owner
- Next action
- Open filing details
3
BWIV
Blue Water Acquisition Corp. IV
- Report period
- 19 Mar 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 19 Mar 2026, 17:11
- Role
- Chief Executive Officer, Director, 10%+ Owner
- Next action
- Open filing details
4
BLUW
Blue Water Acquisition Corp. III
- Report period
- 25 Nov 2025
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 28 Nov 2025, 17:05
- Role
- Chief Executive Officer, Director, 10%+ Owner
- Next action
- Open filing details
4
BLUW
Blue Water Acquisition Corp. III
- Report period
- 11 Jun 2025
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 12 Jun 2025, 16:27
- Role
- Chief Executive Officer, Director, 10%+ Owner
- Next action
- Open filing details
3/A
BLUW
Blue Water Acquisition Corp. III
- Report period
- 09 Jun 2025
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 12 Jun 2025, 16:32
- Role
- Chief Executive Officer, Director, 10%+ Owner
- Next action
- Open filing details
4
ONCO
Blue Water Biotech, Inc.
- Report period
- 09 May 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 11 May 2023, 21:22
- Role
- CEO, Director, 10%+ Owner
- Next action
- Open filing details
4
ONCO
Blue Water Vaccines Inc.
- Report period
- 18 Aug 2022
- Transactions
- 3
- Transaction value
- -$2,640,693
- Accepted by SEC
- 22 Aug 2022, 21:59
- Role
- CEO, Director, 10%+ Owner
- Next action
- Open filing details
4
Clarus Therapeutics Holdings, Inc.
- Report period
- 07 Jun 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 09 Jun 2022, 20:02
- Role
- Director
- Next action
- Open filing details
4
ONCO
Blue Water Vaccines Inc.
- Report period
- 04 May 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 27 May 2022, 10:42
- Role
- CEO, Director, 10%+ Owner
- Next action
- Open filing details
4
Clarus Therapeutics Holdings, Inc.
- Report period
- 25 Apr 2022
- Transactions
- 3
- Transaction value
- +$3,445,000
- Accepted by SEC
- 27 Apr 2022, 16:09
- Role
- Director
- Next action
- Open filing details
3
ONCO
Blue Water Vaccines Inc.
- Report period
- 17 Feb 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 17 Feb 2022, 17:57
- Role
- CEO, 10%+ Owner
- Next action
- Open filing details
4
Clarus Therapeutics Holdings, Inc.
- Report period
- 12 Dec 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 14 Dec 2021, 18:00
- Role
- Director
- Next action
- Open filing details
4/A
Clarus Therapeutics Holdings, Inc.
- Report period
- 09 Sep 2021
- Transactions
- 4
- Transaction value
- +$3,445,000
- Accepted by SEC
- 23 Sep 2021, 16:10
- Role
- Director, Former 10% owner
- Next action
- Open filing details
4
CRXT
CLARUS THERAPEUTICS INC
- Report period
- 09 Sep 2021
- Transactions
- 4
- Transaction value
- +$3,445,000
- Accepted by SEC
- 13 Sep 2021, 19:29
- Role
- Director, Former 10% owner
- Next action
- Open filing details
3
Blue Water Acquisition Corp.
- Report period
- 15 Dec 2020
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 10 Aug 2021, 11:22
- Role
- Chief Executive Officer, Director, 10%+ Owner
- Next action
- Open filing details